COVID - 19 Vaccination Update - Day 530 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 29 JUN 2022 8:17PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 197.60 Crore (1,97,60,22,570) today. More than 12 lakh (12,49,839) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10408930
	2^nd Dose	10065430
	Precaution Dose	5696412
FLWs	1^st Dose	18423887
	2^nd Dose	17626050
	Precaution Dose	10256250
Age Group 12-14 years	1^st Dose	36656801
	2^nd Dose	23394607
Age Group 15-18 years	1^st Dose	60427434
	2^nd Dose	48763009
Age Group 18-44 years	1^st Dose	558247916
	2^nd Dose	501352010
	Precaution Dose	2911714
Age Group 45-59 years	1^st Dose	203445063
	2^nd Dose	193450958
	Precaution Dose	2551515
Over 60 years	1^st Dose	127256942
	2^nd Dose	120828309
	Precaution Dose	24259333
Cumulative 1^st dose administered		1014866973
Cumulative 2^nd dose administered		915480373
Precaution Dose		45675224
Total		1976022570

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 29^th June, 2022 (530^th Day)
HCWs	1^st Dose	57
	2^nd Dose	1605
	Precaution Dose	20718
FLWs	1^st Dose	176
	2^nd Dose	1370
	Precaution Dose	68963
Age Group 12-14 years	1^st Dose	81283
	2^nd Dose	200183
Age Group 15-18 years	1^st Dose	30824
	2^nd Dose	91281
Age Group 18-44 years	1^st Dose	33187
	2^nd Dose	268676
	Precaution Dose	60761
Age Group 45-59 years	1^st Dose	5130
	2^nd Dose	61716
	Precaution Dose	30992
Over 60 years	1^st Dose	5546
	2^nd Dose	42967
	Precaution Dose	244404
Cumulative 1^st dose administered		156203
Cumulative 2^nd dose administered		667798
Precaution Dose		425838
Total		1249839

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.